R R Griffiths
Overview
Explore the profile of R R Griffiths including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
225
Citations
3358
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ross S, Agrawal M, Griffiths R, Grob C, Berger A, Henningfield J
Neuropharmacology
. 2022 Jun;
216:109174.
PMID: 35772523
Psychiatric and existential distress commonly occur in advanced cancer and other serious, life-threatening or end-of-life medical illnesses and are associated with poor medical and psychiatric outcomes. Currently available treatment modalities...
2.
Griffiths R, Richards W, McCann U, Jesse R
Psychopharmacology (Berl)
. 2006 Jul;
187(3):268-83.
PMID: 16826400
Rationale: Although psilocybin has been used for centuries for religious purposes, little is known scientifically about its acute and persisting effects. Objectives: This double-blind study evaluated the acute and longer-term...
3.
Mintzer M, Griffiths R
Behav Pharmacol
. 2005 Sep;
16(7):579-84.
PMID: 16170235
The present double-blind, placebo-controlled study compared the acute effects of oral administration of the benzodiazepine hypnotics flunitrazepam (6 mg/70 kg) and triazolam (1 and 2 mg/70 kg) on measures relevant...
4.
Kaminski B, Sannerud C, Weerts E, Lamb R, Griffiths R
Behav Pharmacol
. 2003 Jul;
14(4):331-42.
PMID: 12838039
Physical dependence on diazepam was evaluated in male baboons chronically treated with either low or high doses of diazepam. Baboons received either a single oral daily administration of a low...
5.
Chausmer A, Smith B, Kelly R, Griffiths R
Behav Pharmacol
. 2003 Mar;
14(2):111-20.
PMID: 12658071
The effects of ecopipam (a D(1) selective antagonist) or triazolam pretreatment on the subjective and physiological effects of intravenously administered nicotine were examined in 10 cigarette-smoking cocaine abusers. Under double-blind,...
6.
Mintzer M, Griffiths R
Behav Pharmacol
. 2002 Dec;
13(8):653-8.
PMID: 12478216
The effects of alcohol (0.80 g/kg) and the benzodiazepine hypnotic triazolam (0.25 mg/70 kg) were compared directly in a double-dummy, double-blind, placebo-controlled, repeated-measures design in 18 healthy volunteers. While alcohol...
7.
Mintzer M, Griffiths R
Psychopharmacology (Berl)
. 2002 Jan;
159(1):51-7.
PMID: 11797069
Rationale: The pattern of acute memory impairment produced by alcohol is similar to that produced by the benzodiazepines. However, in contrast to demonstrations that benzodiazepines decrease false recognition rates, results...
8.
Mintzer M, Griffiths R, Contoreggi C, Kimes A, London E, Ernst M
Neuropsychopharmacology
. 2001 Oct;
25(5):744-56.
PMID: 11682258
It is well documented that acute administration of the benzodiazepine hypnotic drug triazolam (Halcion) impairs episodic memory encoding. We examined the neuroanatomical substrates of this effect in healthy adult volunteers...
9.
Smith B, Jones H, Griffiths R
Psychopharmacology (Berl)
. 2001 Aug;
156(4):435-44.
PMID: 11498721
Rationale: There is little comparative information on the qualitative similarity, relative potency and reinforcing effects of oral cocaine versus cocaine administered via other routes. Methods: The present study used a...
10.
Griffiths R, Chausmer A
Nihon Shinkei Seishin Yakurigaku Zasshi
. 2001 May;
20(5):223-31.
PMID: 11326548
Caffeine is an excellent model compound for understanding drugs of abuse/dependence. The results of self-administration and choice studies in humans clearly demonstrate the reinforcing effects of low and moderate doses...